76 Participants Needed

Transportation Assistance for Cancer Care

(TRACT Trial)

Recruiting at 3 trial locations
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on addressing travel barriers for cancer care.

What data supports the effectiveness of the treatment Transportation for Cancer Care Navigation Tool (TRACT)?

Research on patient navigation programs, which help guide cancer patients through treatment, shows they can improve therapy management, adherence to treatment, and quality of life. These programs often address barriers like transportation, suggesting that TRACT could be effective in helping patients access cancer care.12345

Is the Transportation Assistance for Cancer Care program safe for humans?

The AMAFRICA study found that a similar patient navigation program improved safety for cancer patients by helping them adhere to their treatment. This suggests that programs like Transportation Assistance for Cancer Care are generally safe for humans.12467

How does the transportation assistance treatment for cancer care differ from other treatments?

The transportation assistance treatment for cancer care is unique because it focuses on providing logistical support, such as transportation, to help patients access their cancer treatments. This approach is different from traditional medical treatments as it addresses practical barriers to care, improving adherence and reducing stress for patients.12589

Research Team

JB

Jinbing Bai

Principal Investigator

Emory University Hospital/Winship Cancer Institute

Eligibility Criteria

This trial is for patients with solid tumors who are undergoing radiation therapy and face travel barriers to receive their treatment. It aims to help those who struggle with getting to their appointments due to transportation issues.

Inclusion Criteria

I have been diagnosed with a solid tumor.
English-speaking
I am mentally capable of understanding and agreeing to participate.
See 2 more

Exclusion Criteria

Non-English-speaking (excluded due to pilot data without fund to support translation services)
Enrolled in lodging programs (e.g., the American Cancer Society [ACS] Hope Lodge®)
Have major depression/anxiety disorders that interfere with their ability to participate (based on the electronic medical records report)
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Stage I (CAB)

Participants meet with the study research team to develop and refine the TRACT program

4 weeks
1 visit (in-person)

Stage II (Treatment)

Patients receive either the TRACT program or usual care with PAF pamphlet for 3 months

12 weeks
Multiple visits (in-person and virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months

Treatment Details

Interventions

  • Transportation for Cancer Care Navigation Tool (TRACT)
Trial Overview The study tests the Transportation for Cancer Care Navigation Tool (TRACT), designed to ease travel difficulties for cancer patients receiving radiation therapy. The goal is to see if TRACT can improve adherence to treatment schedules and overall health outcomes.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Stage II Group I (TRACT program)Experimental Treatment2 Interventions
Patients receive the TRACT program consisting: of 1) Screening of travel barriers; 2) Awareness of transportation obstacles and resources using videos, 3) Assistance with transportation resource application and utilization, and 4) Alignment of community resources to navigate individualized transportation support by the trained travel navigator for 3 months.
Group II: Stage I (CAB)Experimental Treatment1 Intervention
Participants meet with the study research team to develop and refine the TRACT program.
Group III: Stage II Group II (usual care, video, pamphlet)Active Control4 Interventions
Patients receive usual care with PAF pamphlet for 3 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

The navigation program for cancer patients showed marginally lower rates of emergency room visits and unplanned hospitalizations among those who used the service, indicating some potential benefits in care coordination.
However, the program had low visibility and utilization among patients, and overall patient experiences were mixed, suggesting that a more focused approach may be needed to effectively support high-risk or anxious patients.
Effectiveness of a Lay Navigation Program in an Academic Cancer Center.Winget, M., Holdsworth, L., Wang, S., et al.[2021]
The implementation of the Ambulatory Medical Assistance (AMA) program for malignant lymphoma patients in Ivory Coast significantly reduced treatment refusal and abandonment compared to a control group, indicating its feasibility and potential benefits in low-middle income countries.
Despite the positive impact on adherence, only one third of patients completed their chemotherapy, and there were no significant differences in treatment outcomes like complete response rate or overall survival, primarily due to financial limitations affecting access to care.
AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study.Koffi, KG., Silué, DA., Laurent, C., et al.[2020]
In a randomized controlled trial involving 319 patients with breast and colorectal cancer, patient navigation did not show a statistically significant effect on cancer-specific quality of life (QOL) compared to usual care.
While the emotional well-being of the patient navigation group showed a change that approached significance, overall QOL measures did not differ significantly, suggesting that patient navigation may not enhance QOL during cancer treatment in this study's context.
Randomized controlled trial of patient navigation for newly diagnosed cancer patients: effects on quality of life.Hendren, S., Griggs, JJ., Epstein, R., et al.[2021]

References

Effectiveness of a Lay Navigation Program in an Academic Cancer Center. [2021]
AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study. [2020]
Randomized controlled trial of patient navigation for newly diagnosed cancer patients: effects on quality of life. [2021]
Clinical outcomes of patient navigation performed by nurses in the oncology setting: an integrative review. [2022]
Implementation of a Theory-based, Non-clinical Patient Navigator Program to Address Barriers in an Urban Cancer Center Setting. [2020]
Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. [2022]
Oncology Nurse Navigation: Development and Implementation of a Program at a Comprehensive Cancer Center . [2018]
Patient navigators improve care of cancer patients. [2008]
Negotiating Lay and Clinical Issues: Implementing a Lay Navigation Program in Cancer Care. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security